Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Precancerous Conditions 1Papillomavirus Infections 1Papilloma 1HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

Cisplatin 27pembrolizumab 21Brachytherapy 16Radiotherapy 14Carboplatin 10Radiation 8Paclitaxel 8Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Topotecan 6fludarabine 5atezolizumab 5Magnetic Resonance Spectroscopy 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Nivolumab 4Gemcitabine 4tremelimumab 3temsirolimus 3human papillomavirus vaccine, L1 type 16, 18 3aldesleukin 3Radiotherapy, Intensity-Modulated 3Papillomavirus Vaccines 3Ipilimumab 3Interleukin-2 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Docetaxel 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Uterine Cervical Neoplasms × Cidofovir × Clear all
NCT02515877 2016-06-09

HPV-RX

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Completed
15 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00811408 2010-01-28

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Unknown
24 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡